Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

Delayed Quote. Delayed  - 09/27 10:02:01 pm
121.22 USD   +1.92%
09/19 EDWARDS LIFESCI : Sapien 3 Transcatheter Heart Valve Receives Expand..
09/01 EDWARDS LIFESCI : To Present At The 11th Annual Wells Fargo Healthca..
08/19 EDWARDS LIFESCI : SAPIEN 3 Transcatheter Heart Valve Receives Expand..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
01:45p EDWARDS LIFESCIENCES : Assigned Patent
09/19 EDWARDS LIFESCIENCES : Sapien 3 Transcatheter Heart Valve Receives Expanded Indi..
09/15 EDWARDS LIFESCIENCES' : Trademark Application for "TRUWAVE IQ" Filed
09/15 EDWARDS LIFESCIENCES : An Application for the Trademark "TIME IN TARGET" Has Bee..
09/15 EDWARDS LIFESCIENCES : Patent Issued for Apparatus and Method for Stent Shaping ..
09/15 EDWARDS LIFESCIENCES : Trademark Application for "MAGNA EASE" Filed by Edwards L..
09/14 EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Se..
09/14 EDWARDS LIFESCIENCES : Assigned Patent
09/07 EDWARDS LIFESCIENCES : Assigned Patent
09/01 EDWARDS LIFESCIENCES : "Bioprosthetic Tissue with Reduced Calcification" in Pate..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/19 Expanded label for Edwards' SAPIEN 3 valve OK'd in Europe
09/13 Steps To Survive The Rate Hike - Cramer's Mad Money (9/12/16)
09/08 VALUATION DASHBOARD : Healthcare - Update
08/25 Dancing With TINA
08/25 Edwards Lifesciences Is A Buy - Cramer's Lightning Round (8/24/16)
Advertisement
Financials ($)
Sales 2016 2 997 M
EBIT 2016 819 M
Net income 2016 596 M
Finance 2016 800 M
Yield 2016 -
P/E ratio 2016 44,80
P/E ratio 2017 35,94
EV / Sales 2016 8,34x
EV / Sales 2017 7,38x
Capitalization 25 805 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 124 $
Spread / Average Target 2,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
John T. Cardis Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..53.48%25 320
THERMO FISHER SCIENTIF..12.01%61 568
BOSTON SCIENTIFIC CORP..28.63%32 290
PHILIPS11.84%27 992
INTUITIVE SURGICAL, IN..31.86%27 224
ILLUMINA, INC.-6.04%26 164
More Results